William Kelly

Director of Finance/CFO at VICARIOUS SURGICAL INC.

Net worth: 155 870 $ as of 30/03/2024

53 year

63 connections

Health Technology

Commercial Services

Consumer Services

Profile

William John Kelly is currently the Chief Financial Officer & Treasurer at Vicarious Surgical, Inc. Prior to this, he was the Chief Financial Officer at Exosome Diagnostics, Inc. and held various financial positions at Repligen Corp., Haemonetics Corp., and SiteScape, Inc. He also worked as an Audit Manager at Ernst & Young LLP and Deloitte & Touche LLP.
Kelly received his undergraduate degree from the College of the Holy Cross and his graduate degree, including an MBA, from Northeastern University.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
VICARIOUS SURGICAL, INC. CLASS A 0.33%	19/03/2024	517,841 ( 0.33% )	155 870 $	30/03/2024

William Kelly active positions

Companies	Position	Start
VICARIOUS SURGICAL INC.	Director of Finance/CFO	16/09/2021

All active positions of William Kelly

Former positions of William Kelly

Companies	Position	End
Exosome Diagnostics, Inc. Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA.	Director of Finance/CFO	31/12/2017
REPLIGEN CORPORATION	Director of Finance/CFO	08/05/2014
HAEMONETICS CORPORATION	Comptroller/Controller/Auditor	31/12/2007
D8 HLDG	Director of Finance/CFO	-

See the detail of William Kelly's experience

Training of William Kelly

College of the Holy Cross (Massachusetts)	Undergraduate Degree
Northeastern University	Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of William Kelly's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	3
REPLIGEN CORPORATION	Health Technology
HAEMONETICS CORPORATION	Health Technology
VICARIOUS SURGICAL INC.	Health Technology

Private companies	4
Ernst & Young LLP Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY.	Commercial Services
Deloitte & Touche LLP Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY.	Commercial Services
D8 Holdings Corp. D8 Holdings Corp. Financial ConglomeratesFinance D8 Holdings Corp. is a blank check company, which is created for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, focusing on regional consumer brands. The company was founded on May 6, 2020 and is headquartered in Hong Kong.	Finance
Exosome Diagnostics, Inc. Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA.	Health Services